nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2B6—Irinotecan—colon cancer	0.187	0.237	CbGbCtD
Primidone—CYP2C9—Capecitabine—colon cancer	0.16	0.202	CbGbCtD
Primidone—CYP2C8—Fluorouracil—colon cancer	0.136	0.172	CbGbCtD
Primidone—CYP1A2—Fluorouracil—colon cancer	0.105	0.133	CbGbCtD
Primidone—CYP2C9—Fluorouracil—colon cancer	0.0948	0.12	CbGbCtD
Primidone—CYP3A4—Irinotecan—colon cancer	0.0575	0.0727	CbGbCtD
Primidone—CYP3A4—Vincristine—colon cancer	0.0502	0.0635	CbGbCtD
Primidone—Personality change—Capecitabine—colon cancer	0.0188	0.0899	CcSEcCtD
Primidone—Anaemia megaloblastic—Methotrexate—colon cancer	0.0114	0.0545	CcSEcCtD
Primidone—Nystagmus—Vincristine—colon cancer	0.00775	0.037	CcSEcCtD
Primidone—Nystagmus—Fluorouracil—colon cancer	0.00723	0.0345	CcSEcCtD
Primidone—Eruption—Methotrexate—colon cancer	0.00437	0.0209	CcSEcCtD
Primidone—Visual disturbance—Irinotecan—colon cancer	0.00413	0.0197	CcSEcCtD
Primidone—Ataxia—Vincristine—colon cancer	0.00378	0.018	CcSEcCtD
Primidone—Ataxia—Fluorouracil—colon cancer	0.00352	0.0168	CcSEcCtD
Primidone—Depression—Vincristine—colon cancer	0.00309	0.0147	CcSEcCtD
Primidone—Connective tissue disorder—Vincristine—colon cancer	0.00273	0.013	CcSEcCtD
Primidone—Agranulocytosis—Fluorouracil—colon cancer	0.0027	0.0129	CcSEcCtD
Primidone—Connective tissue disorder—Irinotecan—colon cancer	0.00266	0.0127	CcSEcCtD
Primidone—Diplopia—Capecitabine—colon cancer	0.00262	0.0125	CcSEcCtD
Primidone—Visual impairment—Irinotecan—colon cancer	0.00261	0.0125	CcSEcCtD
Primidone—Ataxia—Capecitabine—colon cancer	0.00246	0.0118	CcSEcCtD
Primidone—Mental disorder—Vincristine—colon cancer	0.00244	0.0116	CcSEcCtD
Primidone—Anaemia—Vincristine—colon cancer	0.00224	0.0107	CcSEcCtD
Primidone—Anaemia—Irinotecan—colon cancer	0.00218	0.0104	CcSEcCtD
Primidone—Vertigo—Vincristine—colon cancer	0.00217	0.0104	CcSEcCtD
Primidone—Vertigo—Irinotecan—colon cancer	0.00212	0.0101	CcSEcCtD
Primidone—Anaemia—Fluorouracil—colon cancer	0.00209	0.00997	CcSEcCtD
Primidone—Visual disturbance—Methotrexate—colon cancer	0.00206	0.00983	CcSEcCtD
Primidone—Depression—Capecitabine—colon cancer	0.00201	0.00961	CcSEcCtD
Primidone—Nervous system disorder—Vincristine—colon cancer	0.00194	0.00925	CcSEcCtD
Primidone—Nervous system disorder—Irinotecan—colon cancer	0.00189	0.00901	CcSEcCtD
Primidone—Agranulocytosis—Capecitabine—colon cancer	0.00188	0.009	CcSEcCtD
Primidone—Anorexia—Vincristine—colon cancer	0.00188	0.00899	CcSEcCtD
Primidone—Anorexia—Irinotecan—colon cancer	0.00183	0.00876	CcSEcCtD
Primidone—Ataxia—Methotrexate—colon cancer	0.00183	0.00876	CcSEcCtD
Primidone—Nervous system disorder—Fluorouracil—colon cancer	0.00181	0.00863	CcSEcCtD
Primidone—Musculoskeletal discomfort—Vincristine—colon cancer	0.0018	0.0086	CcSEcCtD
Primidone—Connective tissue disorder—Capecitabine—colon cancer	0.00178	0.00851	CcSEcCtD
Primidone—Anorexia—Fluorouracil—colon cancer	0.00176	0.00839	CcSEcCtD
Primidone—Visual impairment—Capecitabine—colon cancer	0.00175	0.00834	CcSEcCtD
Primidone—Decreased appetite—Vincristine—colon cancer	0.00172	0.0082	CcSEcCtD
Primidone—Somnolence—Irinotecan—colon cancer	0.00171	0.00817	CcSEcCtD
Primidone—Gastrointestinal disorder—Vincristine—colon cancer	0.00171	0.00814	CcSEcCtD
Primidone—Fatigue—Vincristine—colon cancer	0.0017	0.00813	CcSEcCtD
Primidone—Eye disorder—Capecitabine—colon cancer	0.00169	0.00809	CcSEcCtD
Primidone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00168	0.00802	CcSEcCtD
Primidone—Decreased appetite—Irinotecan—colon cancer	0.00167	0.00799	CcSEcCtD
Primidone—Gastrointestinal disorder—Irinotecan—colon cancer	0.00166	0.00793	CcSEcCtD
Primidone—Fatigue—Irinotecan—colon cancer	0.00166	0.00792	CcSEcCtD
Primidone—Somnolence—Fluorouracil—colon cancer	0.00164	0.00782	CcSEcCtD
Primidone—Decreased appetite—Fluorouracil—colon cancer	0.0016	0.00765	CcSEcCtD
Primidone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00159	0.0076	CcSEcCtD
Primidone—Mental disorder—Capecitabine—colon cancer	0.00159	0.00758	CcSEcCtD
Primidone—Malnutrition—Capecitabine—colon cancer	0.00158	0.00753	CcSEcCtD
Primidone—Drowsiness—Methotrexate—colon cancer	0.0015	0.00718	CcSEcCtD
Primidone—Depression—Methotrexate—colon cancer	0.0015	0.00716	CcSEcCtD
Primidone—Anaemia—Capecitabine—colon cancer	0.00146	0.00696	CcSEcCtD
Primidone—Vertigo—Capecitabine—colon cancer	0.00142	0.00677	CcSEcCtD
Primidone—Asthenia—Vincristine—colon cancer	0.00142	0.00677	CcSEcCtD
Primidone—Agranulocytosis—Methotrexate—colon cancer	0.0014	0.0067	CcSEcCtD
Primidone—Asthenia—Irinotecan—colon cancer	0.00138	0.00659	CcSEcCtD
Primidone—Arthralgia—Capecitabine—colon cancer	0.00134	0.00641	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00133	0.00637	CcSEcCtD
Primidone—Dizziness—Vincristine—colon cancer	0.00131	0.00624	CcSEcCtD
Primidone—Visual impairment—Methotrexate—colon cancer	0.0013	0.00621	CcSEcCtD
Primidone—Dizziness—Irinotecan—colon cancer	0.00127	0.00608	CcSEcCtD
Primidone—Nervous system disorder—Capecitabine—colon cancer	0.00126	0.00603	CcSEcCtD
Primidone—Eye disorder—Methotrexate—colon cancer	0.00126	0.00602	CcSEcCtD
Primidone—Vomiting—Vincristine—colon cancer	0.00126	0.006	CcSEcCtD
Primidone—Skin disorder—Capecitabine—colon cancer	0.00125	0.00597	CcSEcCtD
Primidone—Rash—Vincristine—colon cancer	0.00125	0.00595	CcSEcCtD
Primidone—Dermatitis—Vincristine—colon cancer	0.00124	0.00594	CcSEcCtD
Primidone—Headache—Vincristine—colon cancer	0.00124	0.00591	CcSEcCtD
Primidone—Anorexia—Capecitabine—colon cancer	0.00123	0.00586	CcSEcCtD
Primidone—Vomiting—Irinotecan—colon cancer	0.00122	0.00584	CcSEcCtD
Primidone—Dizziness—Fluorouracil—colon cancer	0.00122	0.00582	CcSEcCtD
Primidone—Rash—Irinotecan—colon cancer	0.00121	0.00579	CcSEcCtD
Primidone—Dermatitis—Irinotecan—colon cancer	0.00121	0.00579	CcSEcCtD
Primidone—Headache—Irinotecan—colon cancer	0.0012	0.00576	CcSEcCtD
Primidone—Mental disorder—Methotrexate—colon cancer	0.00118	0.00564	CcSEcCtD
Primidone—Malnutrition—Methotrexate—colon cancer	0.00117	0.00561	CcSEcCtD
Primidone—Nausea—Vincristine—colon cancer	0.00117	0.0056	CcSEcCtD
Primidone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00117	0.0056	CcSEcCtD
Primidone—Vomiting—Fluorouracil—colon cancer	0.00117	0.00559	CcSEcCtD
Primidone—Rash—Fluorouracil—colon cancer	0.00116	0.00555	CcSEcCtD
Primidone—Dermatitis—Fluorouracil—colon cancer	0.00116	0.00554	CcSEcCtD
Primidone—Headache—Fluorouracil—colon cancer	0.00115	0.00551	CcSEcCtD
Primidone—Nausea—Irinotecan—colon cancer	0.00114	0.00546	CcSEcCtD
Primidone—Decreased appetite—Capecitabine—colon cancer	0.00112	0.00535	CcSEcCtD
Primidone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00111	0.00531	CcSEcCtD
Primidone—Fatigue—Capecitabine—colon cancer	0.00111	0.0053	CcSEcCtD
Primidone—Nausea—Fluorouracil—colon cancer	0.00109	0.00523	CcSEcCtD
Primidone—Anaemia—Methotrexate—colon cancer	0.00109	0.00518	CcSEcCtD
Primidone—Vertigo—Methotrexate—colon cancer	0.00105	0.00504	CcSEcCtD
Primidone—Arthralgia—Methotrexate—colon cancer	0.001	0.00478	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000993	0.00474	CcSEcCtD
Primidone—Nervous system disorder—Methotrexate—colon cancer	0.00094	0.00449	CcSEcCtD
Primidone—Skin disorder—Methotrexate—colon cancer	0.000931	0.00445	CcSEcCtD
Primidone—Asthenia—Capecitabine—colon cancer	0.000924	0.00441	CcSEcCtD
Primidone—Anorexia—Methotrexate—colon cancer	0.000914	0.00436	CcSEcCtD
Primidone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000873	0.00417	CcSEcCtD
Primidone—Somnolence—Methotrexate—colon cancer	0.000852	0.00407	CcSEcCtD
Primidone—Dizziness—Capecitabine—colon cancer	0.000851	0.00407	CcSEcCtD
Primidone—Decreased appetite—Methotrexate—colon cancer	0.000833	0.00398	CcSEcCtD
Primidone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000827	0.00395	CcSEcCtD
Primidone—Fatigue—Methotrexate—colon cancer	0.000826	0.00395	CcSEcCtD
Primidone—Vomiting—Capecitabine—colon cancer	0.000819	0.00391	CcSEcCtD
Primidone—Rash—Capecitabine—colon cancer	0.000812	0.00388	CcSEcCtD
Primidone—Dermatitis—Capecitabine—colon cancer	0.000811	0.00387	CcSEcCtD
Primidone—Headache—Capecitabine—colon cancer	0.000806	0.00385	CcSEcCtD
Primidone—Nausea—Capecitabine—colon cancer	0.000765	0.00365	CcSEcCtD
Primidone—Asthenia—Methotrexate—colon cancer	0.000688	0.00328	CcSEcCtD
Primidone—Dizziness—Methotrexate—colon cancer	0.000634	0.00303	CcSEcCtD
Primidone—Vomiting—Methotrexate—colon cancer	0.000609	0.00291	CcSEcCtD
Primidone—Rash—Methotrexate—colon cancer	0.000604	0.00289	CcSEcCtD
Primidone—Dermatitis—Methotrexate—colon cancer	0.000604	0.00288	CcSEcCtD
Primidone—Headache—Methotrexate—colon cancer	0.0006	0.00287	CcSEcCtD
Primidone—Nausea—Methotrexate—colon cancer	0.000569	0.00272	CcSEcCtD
